Lumida
/JYNT
⌘K
Joint Corp

Joint Corp

JYNT
$7.85USD-2.24%-0.18 today

MARKET CAP

111.0M

P/E (TTM)

34.1x

FWD P/E

DAY RANGE

$8 – $8

52W RANGE

$8
$11

AI Summary

Stalk
Buy NowMedium

JYNT is in Stage 2 advancing, having built a clear higher‐highs/higher‐lows sequence off its May lows and trading above rising 9/21/50 EMAs on expanding volume. Active Lockout Rally and HH/HL patterns reinforce bullish continuation, while short‐term pullbacks into the EMAs are supported. Despite overbought signals and a declining 200 DMA overhead, timing conditions favor immediate participation to ride further upside momentum.

  • Cash flow from operations jumped 152% YoY to $2.2M
  • Re-franchising reduces company-owned clinics to three, lowering capital needs
  • Same-store sales fell 2.8% in Q2, indicating demand headwinds
Full analysis →

Buying

4

institutions

Selling

4

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL288.62 K2.53 M+-465.91 K-62.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY259.77 K2.28 M+95.60 K+57.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL219.48 K1.93 M+-9.10 K-4.7%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW105.15 K923.24 K+105.15 K+0.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW76.52 K671.84 K+76.52 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY69.54 K610.53 K+49.86 K+250.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL348.002.90 K+-3.54 K-91.3%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL54.00474.00+-148.00-73.5%0.00%